Fortified Health Security Selected by Modern Healthcare as One of the Best Places to Work in Healthcare for 2021
Annual Awards Program Recognizes Outstanding Employers in the Healthcare Industry on a National Level FRANKLIN, TN / ACCESSWIRE / May...
Month: May 2021
CLS Holdings USA, Inc. Now Available for Trading on WealthSimple
LAS VEGAS, NV / ACCESSWIRE / May 17, 2021 / CLS Holdings USA, Inc. (OTCQB:CLSH)(CSE:CLSH), the ''Company'' or ''CLS'', a...
Avinger To Present at the Oppenheimer MedTech, Tools & Diagnostics Summit May 26
REDWOOD CITY, CA / ACCESSWIRE / May 17, 2021 / Avinger, Inc. (NASDAQ:AVGR), a commercial-stage medical device company marketing the...
Halberd Corporation Reports Successful Conjugation of Metallic Particles & SARS-CoV-2 Proprietary Monoclonal Antibody
JACKSON CENTER, PA / ACCESSWIRE / May 17, 2021 / Halberd Corporation (OTC PINK:HALB) announces the successful conjugation of gold-coated...
Jaguar Health, Inc. Reports 2021 First Quarter Financial Results
First quarter 2021 Mytesi gross sales and net sales were approximately $4.6 million and approximately $1.2 million, increases of 250%...
HAVN Life Enters into Agreement to Acquire Clinical Stage IP for Development of LSD-Derived API for Cluster Headaches
HAVN Life works towards substantiating a patent application and preclinical work VANCOUVER, BC / ACCESSWIRE / May 17, 2021 /...
9 Meters Biopharma, Inc. Receives USAN Approval to Use the Designated Nonproprietary Name Vurolenatide for Its Long-Acting GLP-1 Agonist for Short Bowel Syndrome
RALEIGH, NC / ACCESSWIRE / May 17, 2021 / 9 Meters Biopharma, Inc. (NASDAQ:NMTR), a clinical-stage biotechnology company focused on...
StageZero Life Sciences Announces Q1 2021 Financial Results and Operational Update
Q1 Revenue of $2.5 Million TORONTO, ON / ACCESSWIRE / May 17, 2021 / StageZero Life Sciences, Ltd. (TSX:SZLS) ("StageZero"...
Sonnet BioTherapeutics Provides Fiscal Year 2021 Second Quarter Business and Earnings Update
SON-1010, fully-human IL-12 configured using FHAB platform, advancing towards IND submission At-The-Market offering program resulted in net proceeds of $10.2...
NanoViricides Has Filed Quarterly Report for Period Ending March 31, 2021 – Has Sufficient Cash, Coronavirus Drug Candidate Moving Towards IND
SHELTON, CT / ACCESSWIRE / May 17, 2021 / NanoViricides, Inc. (NYSE American:NNVC) (the "Company") a global leader in the...
Turning Point Therapeutics Names Kumar Srinivasan as Executive Vice President, Chief Business Officer
SAN DIEGO, May 17, 2021 (GLOBE NEWSWIRE) -- Turning Point Therapeutics, Inc. (NASDAQ: TPTX), a precision oncology company developing next-generation...
Numi Health Provides COVID-19 Testing for Suncor Energy Workers Departing From Edmonton International Airport
As Alberta copes with the third wave of COVID-19, rapid antigen screening will support the health and safety of essential...
Leading Peer-Reviewed Ophthalmic Journal Publishes Study on ImprimisRx’s Proprietary Klarity-C® Drops
Multi-center Retrospective Study Demonstrates Statistically Significant Reduction in Signs and Symptoms of Dry Eye DiseaseNASHVILLE, Tenn., May 17, 2021 (GLOBE...
Orion Corporation: Disclosure Under Chapter 9 Section 10 of the Securities Market Act (BlackRock, Inc.)
ORION CORPORATION STOCK EXCHANGE RELEASE / MAJOR SHAREHOLDER ANNOUNCEMENTS17 MAY 2021 at 16.00 EEST Orion Corporation: Disclosure Under Chapter...
Skye Bioscience’s THCVHS Demonstrates Superior Therapeutic Benefit Compared to Glaucoma Standard of Care, both as Combination and Single Agent, in Preclinical Study
THCVHS combined with netarsudil (Rhopressa®) achieves an average maximum intraocular pressure (IOP) reduction of 32.4% and maintains an average...
Rafina Innovations Inc. Announces Brand-New Website and Exclusive Distributor Agreement with OPTEC International Inc.
Nicosia, Cyprus, May 17, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire -- Rafina Innovations Inc. (OTC PINK: VICA), a Medical and Pharmaceutical development...
OrthoPediatrics Corp. Continues Double Diamond Sponsorship for 2021 POSNA Meeting
WARSAW, Ind., May 17, 2021 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. (“OrthoPediatrics”) (NASDAQ: KIDS), a company focused exclusively on advancing the...
Decentralized Trials & Research Alliance (DTRA) Announces Priorities and Initial Initiatives
Global Coalition Defines Initiatives to Accelerate the Adoption of Decentralized Research and Improve Access for Participants SAN DIEGO, May 17,...
SCYNEXIS Reports First Quarter 2021 Financial Results and Provides Corporate Update
Secured non-dilutive funding of approximately $35 million thus far in 2021, including licensing payments from Hansoh Pharma, the first tranche...
Orchestra BioMed™ Announces Clinical Data Showing Significant and Sustained Reduction in Systolic Blood Pressure Out to Two Years with BackBeat Cardiac Neuromodulation Therapy™
Clinically meaningful and statistically significant reduction of 16.6 mmHg in systolic blood pressure out to two years 88% of the...